Therefore, we conclude miR‐204 regulates the expression of MMP‐2 and MMP‐9 through the IRAK1/NF‐κB signalling pathway, thereby alleviating T‐ALL in vivo. The gene discussed is MMP9; the disease is acute lymphoblastic leukemia.